{"id":"placebo-aspirin","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Gastrointestinal bleeding"},{"rate":"5-10","effect":"Dyspepsia"},{"rate":"2-5","effect":"Nausea"},{"rate":"<1","effect":"Hemorrhagic stroke"}]},"_chembl":{"chemblId":"CHEMBL25","moleculeType":"Small molecule","molecularWeight":"180.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin acetylates serine residues on COX-1 and COX-2 enzymes, permanently inactivating them and preventing the synthesis of thromboxane A2 in platelets. This reduces platelet activation and aggregation, thereby decreasing the risk of thrombotic events. The placebo component serves as a control in clinical trials to assess the true efficacy of aspirin.","oneSentence":"Aspirin inhibits platelet aggregation by irreversibly blocking cyclooxygenase (COX) enzymes, reducing thromboxane A2 production and preventing clot formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:34.780Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiovascular event prevention (secondary prevention post-myocardial infarction or stroke)"},{"name":"Acute coronary syndrome"}]},"trialDetails":[{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT02965703","phase":"PHASE2","title":"Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-16","conditions":"Colorectal Adenoma, Colorectal Carcinoma","enrollment":81},{"nctId":"NCT05009862","phase":"PHASE4","title":"The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-04-19","conditions":"Peripheral Arterial Disease","enrollment":60},{"nctId":"NCT06757764","phase":"PHASE4","title":"The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-10","conditions":"Cerebral Infarction, Stenosis Artery","enrollment":2340},{"nctId":"NCT07052799","phase":"PHASE3","title":"Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2026-02-10","conditions":"Myocardial Infarction (MI), Cardiovascular Events, Post Polypectomy Bleeding in Antiplatelet Patients","enrollment":2514},{"nctId":"NCT07213778","phase":"PHASE3","title":"REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2025-11-24","conditions":"Symptomatic Venous Thromboembolism (VTE)","enrollment":2000},{"nctId":"NCT02647099","phase":"PHASE3","title":"Adjuvant Low Dose Aspirin in Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anna Martling","startDate":"2016-04-07","conditions":"Colorectal Cancer","enrollment":626},{"nctId":"NCT00713947","phase":"PHASE4","title":"Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-04","conditions":"Positive Helicobacter Pylori Serology, Coronary Thrombosis, Supra-aortic Artery Thrombosis","enrollment":""},{"nctId":"NCT05633810","phase":"PHASE3","title":"COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2022-12-21","conditions":"Diabete Type 2, Cardiovascular Diseases","enrollment":10000},{"nctId":"NCT07257198","phase":"PHASE3","title":"Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-03-03","conditions":"NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction","enrollment":2570},{"nctId":"NCT04697719","phase":"PHASE4","title":"Body Weight, Aspirin Dose and Pro-resolving Mediators","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2021-11-04","conditions":"Body Weight","enrollment":103},{"nctId":"NCT06308952","phase":"PHASE4","title":"Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation","status":"RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2024-07-30","conditions":"Cerebrovascular Event, Stent Stenosis, Ischemic Stroke","enrollment":354},{"nctId":"NCT04809818","phase":"PHASE1","title":"A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects","status":"COMPLETED","sponsor":"Lumosa Therapeutics Co., Ltd.","startDate":"2021-03-21","conditions":"Acute Ischemic Stroke","enrollment":65},{"nctId":"NCT02945033","phase":"PHASE3","title":"Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2018-07-12","conditions":"Colorectal Cancer","enrollment":264},{"nctId":"NCT07205250","phase":"EARLY_PHASE1","title":"Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"The General Hospital of Western Theater Command","startDate":"2026-02-20","conditions":"Type B or Non-A Non-B Aortic Dissection;Thoracic Aortic Aneurysm","enrollment":224},{"nctId":"NCT07243704","phase":"PHASE3","title":"Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Christian Medical College and Hospital, Ludhiana, India","startDate":"2026-02-15","conditions":"Intracerebral Haemorrhage","enrollment":5676},{"nctId":"NCT01275300","phase":"NA","title":"Biosynthesis of PGD2 in Vivo","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2007-07","conditions":"Hyperlipidemia","enrollment":9},{"nctId":"NCT06281665","phase":"PHASE4","title":"Treatment With Aspirin After Preeclampsia: TAP Trial","status":"RECRUITING","sponsor":"Malamo Countouris","startDate":"2024-05-29","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":60},{"nctId":"NCT04040452","phase":"PHASE4","title":"Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery","status":"RECRUITING","sponsor":"Phoenix Children's Hospital","startDate":"2021-03-01","conditions":"Congenital Heart Disease in Children","enrollment":166},{"nctId":"NCT03590821","phase":"EARLY_PHASE1","title":"Timed Aspirin Chronobiome Study","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2027-12","conditions":"Healthy","enrollment":60},{"nctId":"NCT06930885","phase":"PHASE3","title":"Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-06-12","conditions":"Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":7713},{"nctId":"NCT06316570","phase":"PHASE3","title":"Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-04-03","conditions":"Ischemic Stroke, Acute","enrollment":1382},{"nctId":"NCT03667326","phase":"PHASE2","title":"Postpartum Low-Dose Aspirin and Preeclampsia","status":"RECRUITING","sponsor":"Columbia University","startDate":"2019-07-22","conditions":"Preeclampsia Postpartum","enrollment":100},{"nctId":"NCT06408181","phase":"PHASE3","title":"APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-06-12","conditions":"Pre-Eclampsia, Pregnancy Loss","enrollment":1150},{"nctId":"NCT05056896","phase":"EARLY_PHASE1","title":"ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-06-03","conditions":"Colorectal Cancer","enrollment":161},{"nctId":"NCT07113158","phase":"PHASE3","title":"Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Sudden Sensorineural Hearing Loss","enrollment":142},{"nctId":"NCT03480776","phase":"PHASE2","title":"ASA in Prevention of Ovarian Cancer (STICs and STONEs)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-07-24","conditions":"Ovarian Cancer Prevention","enrollment":117},{"nctId":"NCT05310968","phase":"PHASE4","title":"Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2022-11-12","conditions":"Branch Atheromatous Disease","enrollment":970},{"nctId":"NCT05080946","phase":"EARLY_PHASE1","title":"Using Aspirin to Improve Immunological Features of Ovarian Tumors","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2021-11-02","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer","enrollment":100},{"nctId":"NCT06468202","phase":"PHASE4","title":"Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-10-18","conditions":"Hypertensive Disorders of Pregnancy, Preeclampsia, Gestational Hypertension","enrollment":10742},{"nctId":"NCT05604638","phase":"PHASE3","title":"Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Guangxi Medical University","startDate":"2024-04-24","conditions":"Acute Ischemic Stroke","enrollment":348},{"nctId":"NCT07290751","phase":"PHASE4","title":"Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-11-11","conditions":"Acute Ischemic Stroke","enrollment":976},{"nctId":"NCT01729468","phase":"PHASE4","title":"Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2012-06-27","conditions":"Pre-eclampsia, Intra-uterine Growth Restriction","enrollment":1106},{"nctId":"NCT06548971","phase":"PHASE3","title":"Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)","status":"RECRUITING","sponsor":"Capital Medical University","startDate":"2024-11-07","conditions":"Acute Ischemic Stroke, Cerebral Infarction","enrollment":1184},{"nctId":"NCT03079999","phase":"PHASE2","title":"Study of Aspirin in Patients With Vestibular Schwannoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2018-06-11","conditions":"Vestibular Schwannoma, Acoustic Neuroma, Neurofibromatosis 2","enrollment":97},{"nctId":"NCT06168461","phase":"EARLY_PHASE1","title":"Daily Aspirin Treatment After Preeclampsia","status":"RECRUITING","sponsor":"Anna Stanhewicz, PhD","startDate":"2023-11-01","conditions":"Preeclampsia","enrollment":40},{"nctId":"NCT07275749","phase":"PHASE3","title":"Acetyl-leucine in Post-stroke Ataxia","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2025-12-01","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT02394769","phase":"NA","title":"ASPirin Intervention for the REDuction of Colorectal Cancer Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2015-07-06","conditions":"Colorectal Cancer","enrollment":180},{"nctId":"NCT04381143","phase":"PHASE4","title":"ASPIrin in Reducing Events in Dialysis ( ASPIRED )","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2020-07-30","conditions":"CKD (Chronic Kidney Disease) Stage 5D","enrollment":9000},{"nctId":"NCT04479072","phase":"PHASE4","title":"Aspirin and Preeclampsia","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2021-02-15","conditions":"Preeclampsia Postpartum","enrollment":180},{"nctId":"NCT07224347","phase":"","title":"Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anne Murray","startDate":"2019-07-15","conditions":"Functional Disability, Dementia, Heart Disease","enrollment":19114},{"nctId":"NCT02521285","phase":"PHASE2","title":"Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-01-15","conditions":"Barrett Esophagus, Esophageal Adenocarcinoma","enrollment":21},{"nctId":"NCT04526951","phase":"PHASE3","title":"TENecteplase in Central Retinal Artery Occlusion Stuy (TenCRAOS)","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2020-10-30","conditions":"Central Retinal Artery Occlusion","enrollment":81},{"nctId":"NCT06774846","phase":"PHASE3","title":"Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-02","conditions":"Acute Pneumonia, Elderly Person","enrollment":600},{"nctId":"NCT04356326","phase":"PHASE3","title":"Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2021-02-15","conditions":"Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia, Intrauterine Growth Restriction","enrollment":500},{"nctId":"NCT05380063","phase":"PHASE4","title":"Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-02-14","conditions":"Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy","enrollment":2300},{"nctId":"NCT07139639","phase":"EARLY_PHASE1","title":"Evidence-Based Evaluation of Classic Herb Pair (Chuanxiong Rhizoma and Salviae Miltiorrhizae) for Preventing Recurrence of Diabetic Lower Extremity Arterial Disease","status":"NOT_YET_RECRUITING","sponsor":"Zheng Liu","startDate":"2025-11-01","conditions":"Diabetic Lower Extremity Arterial Disease","enrollment":350},{"nctId":"NCT07121569","phase":"PHASE4","title":"Oral DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke: Impact on Inflammatory Biomarkers and Outcomes","status":"COMPLETED","sponsor":"Universitas Sebelas Maret","startDate":"2024-07-06","conditions":"Ischemic Stroke, Acute","enrollment":52},{"nctId":"NCT03326791","phase":"PHASE2, PHASE3","title":"Aspirin in Colorectal Cancer Liver Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oslo University Hospital","startDate":"2017-12-15","conditions":"Colorectal Cancer Liver Metastases, Colorectal Cancer, Liver Metastases","enrollment":466},{"nctId":"NCT04281979","phase":"NA","title":"Effects of a Specific Substance in Smokers","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2020-02-25","conditions":"Smoking","enrollment":60},{"nctId":"NCT06414499","phase":"PHASE3","title":"Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-07-09","conditions":"Minor Ischemic Stroke","enrollment":1386},{"nctId":"NCT06014060","phase":"NA","title":"24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2025-06-20","conditions":"Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent","enrollment":3300},{"nctId":"NCT04217447","phase":"PHASE3","title":"Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease","status":"TERMINATED","sponsor":"University Hospital, Brest","startDate":"2020-05-25","conditions":"Coronary Artery Disease","enrollment":874},{"nctId":"NCT02813824","phase":"PHASE3","title":"Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-11-14","conditions":"Lynch Syndrome","enrollment":852},{"nctId":"NCT06660498","phase":"PHASE1, PHASE2","title":"Pomalidomide as an Immune-enhancing Agent for the Control of HIV","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-05-13","conditions":"HIV-1 Infection","enrollment":32},{"nctId":"NCT03971500","phase":"NA","title":"1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2019-08-20","conditions":"Coronary Artery Disease","enrollment":3710},{"nctId":"NCT02804815","phase":"PHASE3","title":"Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours","status":"ACTIVE_NOT_RECRUITING","sponsor":"University College, London","startDate":"2015-10","conditions":"Cancer, Breast Cancer, Prostate Cancer","enrollment":11000},{"nctId":"NCT05889468","phase":"PHASE4","title":"Postpartum ASA and NT-proBNP","status":"COMPLETED","sponsor":"Duke University","startDate":"2023-07-01","conditions":"Blood Pressure","enrollment":114},{"nctId":"NCT00135226","phase":"PHASE4","title":"ASCEND: A Study of Cardiovascular Events iN Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2005-03","conditions":"Diabetes Mellitus","enrollment":15480},{"nctId":"NCT02467582","phase":"PHASE3","title":"Adjuvant Aspirin Treatment for Colon Cancer Patients","status":"TERMINATED","sponsor":"Swiss Cancer Institute","startDate":"2016-06-09","conditions":"Colon Cancer","enrollment":1040},{"nctId":"NCT03186456","phase":"PHASE1","title":"The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Cerebral Infarction","enrollment":40},{"nctId":"NCT06935994","phase":"PHASE2","title":"Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease","status":"RECRUITING","sponsor":"Taichung Veterans General Hospital","startDate":"2025-05-05","conditions":"Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":120},{"nctId":"NCT05962034","phase":"PHASE4","title":"Thromboxane Function in Women With Endometriosis","status":"RECRUITING","sponsor":"Penn State University","startDate":"2024-01-01","conditions":"Endometriosis","enrollment":96},{"nctId":"NCT05567562","phase":"PHASE2","title":"Anti-Platelets in Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2024-03-27","conditions":"COPD, Emphysema, Emphysema or COPD","enrollment":19},{"nctId":"NCT06915012","phase":"NA","title":"Impact of Biophoton Therapy on Chronic Severe Arthritis Pain","status":"RECRUITING","sponsor":"First Institute of All Medicines","startDate":"2025-03-28","conditions":"Arthritis","enrollment":102},{"nctId":"NCT04770012","phase":"PHASE3","title":"AERIAL Trial: Antiplatelet Therapy in Heart Transplantation","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-06-28","conditions":"Cardiac Allograft Vasculopathy, Heart Transplant","enrollment":135},{"nctId":"NCT04069156","phase":"NA","title":"The ARIES HeartMate 3 Pump IDE Study","status":"COMPLETED","sponsor":"Abbott Medical Devices","startDate":"2020-07-14","conditions":"Heart Failure","enrollment":628},{"nctId":"NCT06105775","phase":"NA","title":"Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-03-06","conditions":"Hypertension in Pregnancy, Hypertension, Pregnancy","enrollment":144},{"nctId":"NCT03377543","phase":"EARLY_PHASE1","title":"Sleep and Inflammatory Resolution Pathway","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2018-06-06","conditions":"Inflammatory Response, Inflammation, Sleep","enrollment":66},{"nctId":"NCT05035316","phase":"PHASE2","title":"Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT)","status":"COMPLETED","sponsor":"Lars Vedel Kessing","startDate":"2022-01-20","conditions":"Bipolar Disorder","enrollment":250},{"nctId":"NCT03047837","phase":"PHASE2","title":"A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients","status":"TERMINATED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2017-03-15","conditions":"Tertiary Prevention in Colon Cancer","enrollment":160},{"nctId":"NCT05253781","phase":"PHASE3","title":"Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)","status":"COMPLETED","sponsor":"University of Lagos, Nigeria","startDate":"2020-07-01","conditions":"Intrauterine Growth Restriction, Preeclampsia, Sickle Cell Disease","enrollment":476},{"nctId":"NCT06756945","phase":"PHASE4","title":"Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-01","conditions":"ST-elevation Myocardial Infarction (STEMI)","enrollment":3612},{"nctId":"NCT03090152","phase":"PHASE4","title":"Minimal Opioid Use After Total Hip Replacement (THR)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-03-08","conditions":"Osteoarthritis, Hip","enrollment":180},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT04214990","phase":"PHASE3","title":"Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients","status":"RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2020-02-15","conditions":"Aspirin, Gastric Cancer","enrollment":1700},{"nctId":"NCT02409680","phase":"NA","title":"Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)","status":"COMPLETED","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2016-03-23","conditions":"Premature Birth","enrollment":11976},{"nctId":"NCT05193071","phase":"PHASE4","title":"Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST)","status":"COMPLETED","sponsor":"General Hospital of Shenyang Military Region","startDate":"2022-07-08","conditions":"Ischemic Stroke","enrollment":1022},{"nctId":"NCT04147013","phase":"PHASE4","title":"Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-02-18","conditions":"Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease","enrollment":44},{"nctId":"NCT04888377","phase":"","title":"ASPIRIN: Neurodevelopmental Follow-up Trial","status":"COMPLETED","sponsor":"NICHD Global Network for Women's and Children's Health","startDate":"2021-09-01","conditions":"Neurodevelopmental Abnormality","enrollment":666},{"nctId":"NCT06100510","phase":"PHASE4","title":"PFA 100 Evaluation and Reference Interval HOACNY","status":"ENROLLING_BY_INVITATION","sponsor":"Hematology Oncology Associates of Central New York","startDate":"2024-02-19","conditions":"Effect of Drug","enrollment":40},{"nctId":"NCT06312800","phase":"PHASE2","title":"Acamprosate and Methazolamide for Essential Tremor","status":"WITHDRAWN","sponsor":"Henry Ford Health System","startDate":"2016-03","conditions":"Essential Tremor","enrollment":""},{"nctId":"NCT02685748","phase":"PHASE2, PHASE3","title":"Aspirin in Young Psychotic Patients","status":"COMPLETED","sponsor":"Clinic for Psychiatric Disorders, Dr Laza Lazarevic","startDate":"2017-07-20","conditions":"Psychosis, Acute Psychosis, Schizophrenia","enrollment":60},{"nctId":"NCT06210646","phase":"PHASE3","title":"Citicoline in Ischemic Stroke, a Randomized Trial","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-12-29","conditions":"Ischemic Stroke","enrollment":800},{"nctId":"NCT03844191","phase":"PHASE1","title":"A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4","status":"COMPLETED","sponsor":"CeleCor Therapeutics","startDate":"2019-02-18","conditions":"Coronary Disease","enrollment":44},{"nctId":"NCT05073718","phase":"PHASE3","title":"SARS-CoV-2 and Acetylsalicylic Acid (SARA)","status":"COMPLETED","sponsor":"Barcelona Institute for Global Health","startDate":"2022-09-14","conditions":"SARS-CoV2 Infection, Covid19","enrollment":38},{"nctId":"NCT03028350","phase":"PHASE2","title":"Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)","status":"COMPLETED","sponsor":"Cumberland Pharmaceuticals","startDate":"2017-07-17","conditions":"Asthma, Aspirin-Induced","enrollment":54},{"nctId":"NCT04146532","phase":"EARLY_PHASE1","title":"Aspirin Effects on Emotional Reactions","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2019-10-08","conditions":"Healthy Adults","enrollment":268},{"nctId":"NCT04031729","phase":"PHASE1, PHASE2","title":"Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-09-12","conditions":"Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis","enrollment":80},{"nctId":"NCT00089895","phase":"PHASE3","title":"EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11-01","conditions":"Myocardial Ischemia, Acute Coronary Syndrome","enrollment":9406},{"nctId":"NCT03120182","phase":"NA","title":"Chronic Subdural Hematoma and Aspirin","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2018-02-19","conditions":"Chronic Subdural Hematoma","enrollment":150},{"nctId":"NCT04122170","phase":"PHASE2","title":"Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old","status":"COMPLETED","sponsor":"SFJ Pharmaceuticals, Inc.","startDate":"2019-09-24","conditions":"Healthy","enrollment":207},{"nctId":"NCT04243278","phase":"EARLY_PHASE1","title":"Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)","status":"TERMINATED","sponsor":"Dr. Graeme Smith","startDate":"2020-09-14","conditions":"Preeclampsia Severe, Cardiovascular Diseases, Primary Prevention","enrollment":14},{"nctId":"NCT04575519","phase":"PHASE2","title":"Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis","status":"RECRUITING","sponsor":"Fundació Institut Germans Trias i Pujol","startDate":"2021-03-04","conditions":"Tuberculosis, Pulmonary, Tuberculosis, MDR, Tuberculosis Infection","enrollment":354},{"nctId":"NCT03464305","phase":"PHASE3","title":"ASPIRIN Trial Belgium","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2018-02-22","conditions":"Colon Cancer","enrollment":148},{"nctId":"NCT02301286","phase":"PHASE3","title":"A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Leiden University","startDate":"2015-01","conditions":"Colon Cancer, Adjuvant Therapy","enrollment":770},{"nctId":"NCT00565708","phase":"PHASE3","title":"Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers","status":"UNKNOWN","sponsor":"National Cancer Centre, Singapore","startDate":"2008-12","conditions":"Colorectal Cancer","enrollment":1587},{"nctId":"NCT03152409","phase":"PHASE2","title":"Salicylic Augmentation in Depression","status":"TERMINATED","sponsor":"Jessica Harder","startDate":"2018-11-15","conditions":"Depression, Depressive Disorder, Major Depressive Disorder","enrollment":32},{"nctId":"NCT03197194","phase":"PHASE3","title":"A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2018-06-08","conditions":"Central Retinal Artery Occlusion","enrollment":70},{"nctId":"NCT05625724","phase":"PHASE3","title":"Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2023-08-02","conditions":"ART, Pre-Eclampsia","enrollment":1164}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3749,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo & Aspirin","genericName":"Placebo & Aspirin","companyName":"Baim Institute for Clinical Research","companyId":"baim-institute-for-clinical-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aspirin inhibits platelet aggregation by irreversibly blocking cyclooxygenase (COX) enzymes, reducing thromboxane A2 production and preventing clot formation. Used for Cardiovascular event prevention (secondary prevention post-myocardial infarction or stroke), Acute coronary syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}